Dysglycemia predicts cardiovascular and kidney disease in the kidney early evaluation program

Journal of Clinical Hypertension

Volumn 12, Issue 1, 2010, Pages 51-58

  Whaley Connell, Adam ^a   Pavey, Brian S ^a   McCullough, Peter A ^b   Saab, Georges ^a   Li, Suying ^c   McFarlane, Samy I ^d   Chen, Shu Cheng ^c   Vassalotti, Joseph A ^e   Collins, Allan J ^c   Bakris, George ^f   Sowers, James R ^a  

^a University of Missouri   (United States)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

^c MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^d SUNY DOWNSTATE MEDICAL CENTER   (United States)

^e NATIONAL KIDNEY FOUNDATION   (United States)

^f UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DISORDERS OF CARBOHYDRATE METABOLISM; DYSGLYCEMIA; DYSLIPIDEMIA; EARLY DIAGNOSIS; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH PROGRAM; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; RISK ASSESSMENT; SCREENING TEST; TREND STUDY; BLOOD; CHRONIC DISEASE; METABOLISM; MIDDLE AGED; PREDICTION AND FORECASTING;

ADULT; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; FEMALE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE;

EID: 77949366892     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2009.00190.x     Document Type: Article

References (23)

1. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288(21): 2709-2716.
2. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24(4):683-689.
3. American Heart Association (AHA). Heart Disease and Stroke Statistics-2005 Update. Dallas, TX: American Heart Association; 2005.
4. Chen J, Muntner P, Hamm L, et al. The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med. 2004;140(3):167-175.
5. Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004;110(10):1245-1250.
6. Coresh J, Byrd-Holt D, Astor BC, et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol. 2005;16:180-188.
7. Foley RN, Murray AM, Li S, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol. 2005;16:489-495.
8. Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol. 2005;16:2134-2140.
9. Lea J, Cheek D, Thornley-Brown D, et al; AASK Study Investigators. Metabolic syndrome, proteinuria, and the risk of progressive CKD in hypertensive African Americans. Am J Kidney Dis 2008;51(5):732-740.
10. Lucove J, Vupputuri S, Heiss G, et al. Metabolic syndrome and the development of CKD in American Indians: the Strong Heart Study. Am J Kidney Dis. 2008;51(1):21-28.
11. Jurkovitz CT, Qiu Y, Wang C, et al. The Kidney Early Evaluation Program (KEEP): program design and demographic characteristics of the population. Am J Kidney Dis. 2008;51(4):S3-S12.
12. Whaley-Connell AT, Sowers JR, Stevens LA, et al; Kidney Early Evaluation Program Investigators. CKD in the United States: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis. 2008; 51(4 suppl 2):S13-S20.
13. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247-254.
14. McCullough PA, Jurkovitz CT, Pergola PE, et al; for the KEEP Investigators. Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP). Arch Intern Med. 2007;167(11):1122-1129.
15. Chen J, Muntner P, Hamm LL, et al. Insulin resistance and risk of chronic kidney disease in non diabetic US adults. J Am Soc Nephrol. 2003;14:469-477.
16. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-359.
17. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
18. Gelber RP, Kurth T, Kausz AT, et al. Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis. 2005;46:871-880.
19. Hsu CY, McCulloch CE, Iribarren C, et al. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006;144:21-28.
20. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-853.
21. Hovind P, Rossing P, Tarnow L, et al. Progression of diabetic nephropathy. Kidney Int. 2001;59:702-709.
22. Fioretto P, Bruseghin M, Berto I, et al. Renal protection in diabetes: role of glycemic control. J Am Soc Nephrol. 2006;17(suppl 2):S86-S89.
23. Menon V, Greene T, Pereira AA, et al. Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney disease. J Am Soc Nephrol. 2005;16:3411-3417.